Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Nurexone Biologic Inc (NRXBF)

Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis GlobeNewswire - Fri Dec 19, 2025

TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) today announced new laboratory data...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways GlobeNewswire - Fri Dec 12, 2025

TORONTO and HAIFA, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-biotechnology company...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Fri Nov 28, 2025

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.  (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises GlobeNewswire - Wed Nov 12, 2025

TORONTO and HAIFA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) is pleased to announce that, further...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing GlobeNewswire - Mon Nov 3, 2025

TORONTO and HAIFA, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) announced today that it has been accepted...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK GlobeNewswire - Tue Oct 21, 2025

TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model GlobeNewswire - Wed Oct 8, 2025

TORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) a biopharmaceutical company developing...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana GlobeNewswire - Tue Sep 16, 2025

TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing GlobeNewswire - Thu Sep 11, 2025

TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a pioneering biopharmaceutical company...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness GlobeNewswire - Mon Sep 8, 2025

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company...

NRX.VN : 0.640 (-1.54%)
NRXBF : 0.4679 (+2.63%)

Barchart Exclusives

2 High-Yield Dividend Aristocrats to Consider in 2026 Barchart - Mon Jan 12, 6:30PM CST
These Dividend Aristocrats stand out due to their relatively high yields. Moreover, both these companies have the potential for continued dividend growth in the years ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot